Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 35 Records) |
| Query Trace: Lymphoma and Tet2[original query] |
|---|
| Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium. PloS one 2014 9 (3): e89791. Lim Unhee, Kocarnik Jonathan M, Bush William S, Matise Tara C, Caberto Christian, Park Sungshim Lani, Carlson Christopher S, Deelman Ewa, Duggan David, Fesinmeyer Megan, Haiman Christopher A, Henderson Brian E, Hindorff Lucia A, Kolonel Laurence N, Peters Ulrike, Stram Daniel O, Tiirikainen Maarit, Wilkens Lynne R, Wu Chunyuan, Kooperberg Charles, Le Marchand Lo |
| Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematological oncology 2016 Jun . Saillard Colombe, Guermouche Helene, Derrieux Coralie, Bruneau Julie, Frenzel Laurent, Couronne Lucile, Asnafi Vahid, Macintyre Elizabeth, Trinquand Amélie, Lhermitte Ludovic, Molina Thierry, Suarez Felipe, Lemonnier Francois, Kosmider Olivier, Delarue Richard, Hermine Olivier, Cheminant Morga |
| TET2 Mutation in Adult T-Cell Leukemia/Lymphoma. Journal of clinical and experimental hematopathology : JCEH 2015 55 (3): 145-9. Shimoda Kazuya, Shide Kotaro, Kameda Takuro, Hidaka Tomonori, Kubuki Yoko, Kamiunten Ayako, Sekine Masaaki, Akizuki Keiichi, Shimoda Haruko, Yamaji Takumi, Nakamura Kenichi, Abe Hiroo, Miike Tadashi, Iwakiri Hisayoshi, Tahara Yoshihiro, Sueta Mitsue, Yamamoto Shojiro, Hasuike Satoru, Nagata Kenji, Kitanaka Aki |
| Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression. Oncotarget 2017 9 8 (32): 52256-52268. Marçais Ambroise, Waast Laetitia, Bruneau Julie, Hanssens Katia, Asnafi Vahid, Gaulard Philippe, Suarez Felipe, Dubreuil Patrice, Gessain Antoine, Hermine Olivier, Pique Claudi |
| Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies. Annals of hematology 2018 8 98 (1): 185-193. Gao Xiao-Ning, Lin Ji, Wang Shu-Hong, Huang Wen-Rong, Li Fei, Li Hong-Hua, Chen Jing, Wang Li-Jun, Gao Chun-Ji, Yu Li, Liu Dai-Ho |
| Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma. Familial cancer 2018 Aug . Donner Iikki, Katainen Riku, Kaasinen Eevi, Aavikko Mervi, Sipilä Lauri J, Pukkala Eero, Aaltonen Lauri |
| Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia. Bratislavske lekarske listy 2018 119 (6): 366-372. Akin D F, Oner D A, Kurekci E, Akar |
| Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood cancer journal 2018 Jun 8 (6): 60. Intlekofer Andrew M, Joffe Erel, Batlevi Connie L, Hilden Patrick, He Jie, Seshan Venkatraman E, Zelenetz Andrew D, Palomba M Lia, Moskowitz Craig H, Portlock Carol, Straus David J, Noy Ariela, Horwitz Steven M, Gerecitano John F, Moskowitz Alison, Hamlin Paul, Matasar Matthew J, Kumar Anita, van den Brink Marcel R, Knapp Kristina M, Pichardo Janine D, Nahas Michelle K, Trabucco Sally E, Mughal Tariq, Copeland Amanda R, Papaemmanuil Elli, Moarii Mathai, Levine Ross L, Dogan Ahmet, Miller Vincent A, Younes An |
| Mutation analysis of therapy-related myeloid neoplasms. Cancer genetics 2018 4 222-223 38-45. Nishiyama Takahiro, Ishikawa Yuichi, Kawashima Naomi, Akashi Akimi, Adachi Yoshiya, Hattori Hikaru, Ushijima Yoko, Kiyoi Hitos |
| A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. Applied immunohistochemistry & molecular morphology : AIMM 2018 4 27 (6): 416-422. Fernandez-Pol Sebastian, Ma Lisa, Joshi Rohan P, Arber Daniel |
| Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders. Cancer biology & therapy 2019 7 20 (10): 1319-1327. Gao Li-Min, Zhao Sha, Zhang Wen-Yan, Wang Mi, Li Hui-Fang, Lizaso Anle, Liu Wei-Pi |
| The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 4 32 (8): 1123-1134. Steinhilber Julia, Mederake Moritz, Bonzheim Irina, Serinsöz-Linke Ebru, Müller Inga, Fallier-Becker Petra, Lemonnier François, Gaulard Philippe, Fend Falko, Quintanilla-Martinez Letic |
| Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for RHOA G17V mutated subtype. Leukemia & lymphoma 2019 12 61 (5): 1108-1118. Hsu Ya-Ting, Wang Yu-Chu, Chen Ruo-Yu, Hung Liang-Yi, Li Sin-Syue, Yen Chi-Chieh, Chen Tsai-Yun, Medeiros L Jeffrey, Chang Kung-Ch |
| [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2019 10 48 (10): 784-790. Guo Y M, Liu X F, Jiao L J, Yin S Y, Wang Z, Li X X, Ma Z P, Yang J M, He M |
| Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. Cancer 2020 May . Lee Michelle J, Koff Jean L, Switchenko Jeffrey M, Jhaney C Ileen, Harkins R Andrew, Patel Sharvil P, Dave Sandeep S, Flowers Christopher |
| Genomic Alterations and MYD88 Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. Targeted oncology 2020 4 15 (2): 221-230. Jiang Shiyu, Qin Yan, Gui Lin, Liu Peng, Jiang Hongxin, Liu Biao, Yang Jianliang, Yang Sheng, He Xiaohui, Zhou Shengyu, Du Xinhua, Yi Yuting, Lin Jing, Shi Yuank |
| Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. eLife 2021 9 10 . Cheng Shuhua, Zhang Wei, Inghirami Giorgio, Tam Way |
| Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG). British journal of haematology 2021 7 194 (4): 718-729. Ohki Kentaro, Kiyokawa Nobutaka, Watanabe Satoru, Iwafuchi Hideto, Nakazawa Astuko, Ishiwata Keisuke, Ogata-Kawata Hiroko, Nakabayashi Kazuhiko, Okamura Kohji, Tanaka Fumiko, Fukano Reiji, Hata Kenichiro, Mori Tetsuya, Moriya Saito Akiko, Hayashi Yasuhide, Taga Takashi, Sekimizu Masahiro, Kobayashi Ryoji, |
| Thyroid MALT lymphoma: self-harm to gain potential T-cell help. Leukemia 2021 5 35 (12): 3497-3508. Wu Fangtian, Watanabe Natsuko, Tzioni Maria-Myrsini, Akarca Ayse, Zhang Chunye, Li Yan, Chen Zi, Cucco Francesco, Carmell Natasha, Noh Jaeduk Yoshimura, Ito Koichi, Dobson Rachel, Moody Sarah, Yao Wenqing, Zhang Wenyan, Liu Weiping, Liu Hongxiang, Okosun Jessica, Chott Andreas, Bi Yingwen, Chuang Shih-Sung, Raderer Markus, Li Jian-Yong, Marafioti Teresa, Du Ming-Qi |
| Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. Experimental hematology & oncology 2021 Feb 10 (1): 9. Ye Yingying, Ding Ning, Mi Lan, Shi Yunfei, Liu Weiping, Song Yuqin, Shu Shaokun, Zhu J |
| Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells. Blood 2021 1 137 (23): 3237-3250. Pastoret Cédric, Desmots Fabienne, Drillet Gaëlle, Le Gallou Simon, Boulland Marie-Laure, Thannberger Alexia, Doncker Anne-Violaine, Salaun Véronique, Damaj Gandhi Laurent, Veyrat-Masson Richard, Tournilhac Olivier, Moignet Aline, Pangault Céline, Roussel Mikaël, Fest Thierry, Lamy Thier |
| Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. Blood advances 2021 Jan 5 (2): 539-548. Lemonnier François, Safar Violaine, Beldi-Ferchiou Asma, Cottereau Anne-Ségolène, Bachy Emmanuel, Cartron Guillaume, Fataccioli Virginie, Pelletier Laura, Robe Cyrielle, Letourneau Audrey, Missiaglia Edoardo, Fourati Slim, Moles-Moreau Marie-Pierre, Delmer Alain, Bouabdallah Reda, Voillat Laurent, Becker Stéphanie, Bossard Céline, Parrens Marie, Casasnovas Olivier, Cacheux Victoria, Régny Caroline, Camus Vincent, Delfau-Larue Marie-Hélène, Meignan Michel, de Leval Laurence, Gaulard Philippe, Haioun Corin |
| CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. Signal transduction and targeted therapy 2021 Jan 6 (1): 10. Huang Yao-Hui, Cai Kun, Xu Peng-Peng, Wang Li, Huang Chuan-Xin, Fang Ying, Cheng Shu, Sun Xiao-Jian, Liu Feng, Huang Jin-Yan, Ji Meng-Meng, Zhao Wei- |
| The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. Annals of hematology 2022 4 101 (6): 1227-1237. Gramegna Doriana, Bertoli Diego, Cattaneo Chiara, Almici Camillo, Re Alessandro, Belotti Angelo, Borlenghi Erika, Lanzi Gaetana, Archetti Silvana, Verardi Rosanna, Brugnoni Duilio, Sciumè Margherita, Daffini Rosa, Roccaro Aldo M, Tucci Alessandra, Rossi Giusep |
| Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 2022 4 36 (6): 1654-1665. Wong Jonathan, Gruber Emily, Maher Belinda, Waltham Mark, Sabouri-Thompson Zahra, Jong Ian, Luong Quinton, Levy Sidney, Kumar Beena, Brasacchio Daniella, Jia Wendy, So Joan, Skinner Hugh, Lewis Alexander, Hogg Simon J, Vervoort Stephin, DiCorleto Carmen, Uhe Micheleine, Gamgee Jeanette, Opat Stephen, Gregory Gareth P, Polekhina Galina, Reynolds John, Hawkes Eliza A, Kailainathan Gajan, Gasiorowski Robin, Kats Lev M, Shortt Ja |
| Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias. Seminars in oncology 2022 12 . Testa Stefano, Kumar Jyoti, Goodell Alex J, Zehnder James L, Alexander Kevin M, Sidana Surbhi, Arai Sally, Witteles Ronald M, Liedtke Michae |
| Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients. Advanced biology 2023 9 e2300042. Cunte Chen, Ling Huang, Zheng Chen, Qiuxiang Ou, Sichu Liu, Xinmiao Jiang, Feili Chen, Xiaojuan Wei, Hanguo Guo, Yang Shao, Chengwu Zeng, Yangqiu Li, Wenyu |
| Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes. Cancer research and treatment 2023 7 . Jin Ju Kim, Hye Min Kim, Hongkyung Kim, Soo-Jeong Kim, Seung-Tae Lee, Jong Rak Choi, Saeam Shin, Doh Yu Hwa |
| Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 2023 3 7 e2200583. Aldea Mihaela, Tagliamento Marco, Bayle Arnaud, Vasseur Damien, Vergé Véronique, Marinello Arianna, Danlos François-Xavier, Blanc-Durand Felix, Bernard Elsa, Cerbone Luigi, Mosele Maria Fernanda, Renneville Aline, Hadoux Julien, Loriot Yohann, Sakkal Madona, Vozy Aurore, Sarkozy Clementine, Smolenschi Cristina, Nicotra Claudio, Martin-Romano Patricia, Boccon-Gibod Clementine, Habza Wafikaamira, Lazarovici Julien, Ponce Santiago, Hollebecque Antoine, Marzac Christophe, Lacroix Ludovic, Barlesi Fabrice, André Fabrice, Besse Benjamin, Rouleau Etienne, Italiano Antoine, Micol Jean-Baptis |
| TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients. Cancer 2023 2 . Cho Junhun, Kim Eojin, Yoon Sang Eun, Kim Seok Jin, Kim Won Se |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: